Company intelligence / Profile preview
TechnoVax
Tarrytown, New York, United Statestechnovax.com ↗
- Ownership
- Private
- Employees
- ~30
- Development stage
- Other
01
Overview
TechnoVax has achieved successful preclinical milestones with several VLP-based vaccine candidates (including pandemic influenza strains H5N1, H7N7, H1N1-1918, RSV and Zika) and, as of available data, all proprietary programs remain in the preclinical stage without reported human clinical trial results.[3][5]
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- VaccineVirus-like particle vaccineBiologic
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
National Institutes of Health (NIH)[2][3]Centers for Disease Control and Prevention (CDC)[2]Wyeth (technology license for VLP platform)[3]
Beyond the preview
Go deeper on TechnoVax.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TechnoVax.